Analytical Data
-
基因名
IL-13Rα1
-
简介
The IL13RA1 protein is critical in immune signaling and binds with low affinity to IL13. It binds to IL4RA to form a functional IL13 receptor for cellular responses. IL-13R alpha 1 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived IL-13R alpha 1 protein, expressed by HEK293 , with C-His, C-Avi labeled tag.
- Application
-
别名
IL-13 R alpha 1; IL13R; IL13RA; CT19; IL13RA1; NR4; CD213A1; AI882074
-
种属
Human
-
表达系统
HEK293
-
标签
C-Avi;C-8*His
-
纯度
> 90% as determined by SDS-PAGE.
-
蛋白编号
P78552
-
表达区间
A27-T343
-
蛋白长度
Partial
-
分子量
55-75 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interleukin-13 receptor subunit alpha-1 (IL-13Rα1) is a key player in the signaling pathways of interleukin-13 (IL-13), a cytokine involved in various biological processes, including immune response and inflammation. Abnormal IL-13 signaling is implicated in a range of diseases, particularly allergic conditions such as asthma, as well as fibrosis in organs like the lungs and liver. The IL-13Rα1 protein is known to form a functional receptor complex with IL-4Rα, enabling the modulation of cellular responses in immune cells. Due to its pivotal role in mediating the effects of IL-13, IL-13Rα1 has emerged as a potential therapeutic target for treating asthma and other IL-13 related disorders. Researchers have focused on developing recombinant IL-13Rα1 proteins to study their structure, function, and interactions with IL-13 and IL-4. These studies are essential for understanding the molecular mechanisms underlying IL-13 signaling and the development of new therapeutic strategies. Additionally, recombinant IL-13Rα1 could serve as a valuable tool in the development of novel antibodies or inhibitors, potentially leading to improved treatments for inflammatory diseases. Overall, the investigation of IL-13Rα1 recombinant proteins holds significant promise for advancing our understanding of IL-13-related pathologies and developing innovative treatment options.
